Calithera Biosciences Investor Relations Material

Calithera Biosciences Inc. is a clinical-stage biotechnology company focused on discovering and developing small-molecule therapies targeting cancer and other debilitating diseases. The company’s research is centered on developing drugs that inhibit tumor metabolism and modulate the immune system to treat cancer and other conditions. Calithera’s lead programs involve targeting metabolic pathways in tumor cells and immune cells to improve patient outcomes. The company is headquartered in South San Francisco, California, USA, and its shares are listed on the NASDAQ.